Experimental drug combo targets tough leukemias in early trial
NCT ID NCT03132454
First seen Nov 03, 2025 · Last updated May 16, 2026 · Updated 34 times
Summary
This early-stage study tests a drug called palbociclib, given alone or with other medicines (sorafenib, decitabine, or dexamethasone), in 32 adults whose leukemia has returned or not responded to prior therapy. The main goal is to find the safest dose and check for side effects. This is not a cure trial; it aims to control the disease in people with few other options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.